N-(2-chlorophenyl)-6-(piperidin-1-yl)imidazo[1,2-a]pyridine-3-carboxamide

ID: ALA1078840

PubChem CID: 46175116

Max Phase: Preclinical

Molecular Formula: C19H19ClN4O

Molecular Weight: 354.84

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccccc1Cl)c1cnc2ccc(N3CCCCC3)cn12

Standard InChI:  InChI=1S/C19H19ClN4O/c20-15-6-2-3-7-16(15)22-19(25)17-12-21-18-9-8-14(13-24(17)18)23-10-4-1-5-11-23/h2-3,6-9,12-13H,1,4-5,10-11H2,(H,22,25)

Standard InChI Key:  PAPLYPMKGDNISY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    8.4868  -20.8083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4857  -21.6354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2003  -22.0482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1985  -20.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9136  -20.8047    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9184  -21.6308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7056  -21.8816    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1873  -21.2104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6978  -20.5450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7147  -19.7222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4364  -19.3229    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.0082  -19.2969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0232  -18.4724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7493  -18.0765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7647  -17.2528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0598  -16.8338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3336  -17.2303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3218  -18.0527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6015  -18.4544    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.7733  -20.3963    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7751  -19.5707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0649  -19.1587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3484  -19.5676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3466  -20.3933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0613  -20.8099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 10 12  1  0
  2  3  2  0
 12 13  1  0
  3  6  1  0
 13 14  2  0
  1  2  1  0
 14 15  1  0
  5  4  1  0
 15 16  2  0
  6  7  2  0
 16 17  1  0
  7  8  1  0
 17 18  2  0
 18 13  1  0
  8  9  2  0
 18 19  1  0
 20 21  1  0
  9  5  1  0
  4  1  2  0
  9 10  1  0
  5  6  1  0
 10 11  2  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
  1 20  1  0
M  END

Associated Targets(Human)

EPHB3 Tchem Ephrin type-B receptor 3 (1881 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 354.84Molecular Weight (Monoisotopic): 354.1247AlogP: 4.23#Rotatable Bonds: 3
Polar Surface Area: 49.64Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.34CX LogP: 3.33CX LogD: 3.33
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.77Np Likeness Score: -1.97

References

1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD..  (2009)  Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors.,  19  (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010]

Source